Transcript Slide 1

Sarz Maxwell MD FASAM
sarzmaxmd @yahoo.com.
www. AnyPositiveChange.org
“… he was nodding and then I
looked over and he was … well,
there’s a smell, you know?
I knew he was dead.
And I didn’t know what to do, I just
parked the car and got on the bus.
He was dead. What could I do?”
500
450
400
350
300
250
200
150
100
50
0
1996
1997
1998
1999
2000
1996
1997
1998 1999
2000
The diagnosis and management of anaphylaxis.
SOURCE(S):
J Allergy Clin Immunol 1998 Jun;101(6 Pt 2):S465-S528 [337 references]
MAJOR RECOMMENDATIONS:
Patient education may be the most important preventive strategy.
Patients should be carefully instructed about hidden allergens, crossreactions to various allergens, unforeseen risks during medical
procedures and when and how to use self-administered epinephrine.
Standards of medical care for patients with
diabetes mellitus.
SOURCE(S):
Diabetes Care 2001 Jan;24(Suppl 1):S33-S43 [32 references]
MAJOR RECOMMENDATIONS:Family members and close associates
of the patient who uses insulin should be taught to use glucagon.





Pure opiate antagonist
>40 years experience by emergency
personnel for OD reversal
Only effect is blockade of opiate
receptor
Not addictive; no potential for
abuse
No side effects except precipitation
of withdrawal
 Dose- and delivery-sensitive
Options
Advantages
Disadvantages
Single-dose Pre-measured
pre-loaded No add’l
syringe
equipment
Cost (~$15 USD /dose)
Fragile apparatus
Single dose
Intranasal
atomizer
No needles
Premeasured
Cost (~10 USD /dose)
Slightly less efficacy
Single dose
Multi-dose
multi-use
10cc vial
Cost (~$0.27 /dose) Need add’l needles
Multiple doses
?contamination?
Very portable /
durable



Average heroin user has witnessed 4 OD’s,
at least 1 of them fatal
Deaths of peers & personal experience with
OD do not ‘teach’ actively-using heroin
addicts to stop using heroin
Heroin addicts are interested in helping
other addicts in trouble


Participants definitely motivated to
intervene in OD situations
Participant focus groups informed
program development
Low threshold
 Multi-dose vial formulation




89% approve the idea
92% express willingness to attend
training session
Concerns:
Police harrassment & legality of naloxone
possession
 Fear of dopesickness

 Dose- and delivery-sensitive
Wright et al 2006 UK
Kerr et all 2008 Australia
“I was just freakin’ out,
thinking: ‘I wish I knew
how to do CPR’…
and I was like,
‘Oh, why don’t I know this?’”




Death of CRA co-founder in 1997
Begin distributing naloxone in 1997
2000 actively expanding program
Train all CRA operatives to educate and
distribute

US law allows a prescription to be written when a
doctor-patient relationship exists






Chart
Documentation of education RE prescription
Medical director trained CRA operatives to educate
& distribute
Intake form developed with brief history, checklist
for education, and standing order
OEND occurred at all 22 weekly SEP sites plus cell
phone on-call
Participants quickly became distributors





OD Prevention
Early Recognition
› Unresponsive
› Before cyanosis
Rescue Breathing
Naloxone administration
› 1 cc (0.4 mg) IM
› > 1” needle
› Multi-use vial
Aftercare
› Do not use more opiate!
 High will return in 30-40 min
›
›
Return of OD
Transport for medical f/u


Age > 34
Using in combination with other drugs
 Alcohol
 Cocaine
PONS
Respiratory Centre
Opiates depress
respiratory drive
MEDULLA
Cardiac Centre
Cocaine stimulates
heartbeat, blood
pressure



Mixing drugs
Using alone
Recent period of abstinence –
as brief as 3 days will decrease
tolerance
Detox program
 Incarceration

“He got out of the joint… came back,
thought he had the same tolerance…
but he didn’t…
… I put
myself in detox and I
got out, shot up a
bag … and he was
with me, thank god,
because I went out.”
Drug
Duration
potency
Methadone
24 hr
++++
Heroin
6 – 8 hr
+++++
Oxycodone
3 – 6 hr
+++++
Codeine
3 – 4 hr
+
Demerol
2 – 4 hr
++
Morphine
3 – 6 hr
+++
Fentanyl
2 - 4 hr
++++++++
++++++++
++++++++
500
450
400
350
300
250
200
150
100
50
0
1996
2000
2004
2007
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
NALOXONE
Empowerment
+
New Message:
“it matters if you
live or die”
community,
altruism
Hope
Future-orientation
“I did something that
made a difference. The
whole world can’t see it
but I know it made a
difference. And that’s
important… to me.”




Statewide program supported by state DPH
Operating in 13 communities
SEPs, drop-in centers, treatment programs ( detox,
OTP, residential tx, inpt), ER, home visits, street
outreach
>9000 enrolled, ~1000 reversals (11%)

Top 3 most common sites for OTP patient naloxone
refills:
Needle Exchange Program (40%)
 Drop-in Center (30%)
 Methadone Clinic (9%)

Slide courtesy Maya Doe-Simkins


70 patients with opioid dependence syndrome in
abstinence-based program trained & given
naloxone
6 mos later, participants had retained knowledge,
still had the naloxone, but none had used it



Transportability
Stigma
Fear of police
Harm Reduct J, 2009 Sep 24; 6:26





Low threshold – on demand, easily accessible,
minimal paperwork
Education – duration; by whom
Venue – user-friendly
Formulation – simple, durable
Doses and Refills – multiple doses



OD relapse
Multiple simultanerous victims
Abundance >> Confidence
“It used to be, overdose, you always
talked about it in past tense: ‘I HAD
a friend who OD’d.’ Now, overdose
is in the present tense: ‘I HAVE a
friend who OD’d last week’.
Naloxone did that.”





Dan Bigg
Karen Stanczykiewiz
Greg Scott
Suzanne Carlberg –
Racich
John Gutenson



Susie Gualtieri
Sharon Sereda
Esther, Cheryl, Cliff, Andrew …
All of our courageous
participants, who make this
program work

the end(s)
www. AnyPositiveChange .org
sarzmaxmd @ yahoo.com